ArcticDx Comes to US, Eyes FDA Approval for AMD Test | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Just having embarked on its US sales strategy, Canadian molecular diagnostics firm ArcticDx is targeting a mid-2011 submission to the US Food and Drug Administration for approval of its age-related macular degeneration prognostic test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.